Skip to main content
Year archive

BioPorto — 2021 filings

All 29 regulatory filings released by BioPorto (BIOPOR) in 2021, sourced directly from the official regulator.

29 Filings
2021 Period
2021 filings (29)
Filing Released Lang
In an effort to prioritize Emergency Use Authorizations (EUA), the FDA does not recommend that BioPorto pursue an EUA for its NGAL assay for the prediction of renal replacement therapy in COVID-19 pa
Regulatory Filings
2021-11-19 English
Legal Proceedings Report 2021
Legal Proceedings Report
2021-11-19 English
BioPorto Announces Q3 2021 Report
Report Publication Announcement 9M 2021
2021-11-17 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-17 English
Update on Patient Enrollment for Pivotal Study of NGAL in Pediatrics
Regulatory Filings
2021-11-03 English
Regulatory Filings 2021
Regulatory Filings
2021-11-03 English
BioPorto A/S appoints new Chief Financial Officer
Board/Management Information
2021-10-20 English
Board/Management Information 2021
Board/Management Information
2021-10-20 English
BioPorto A/S appoints new Chief Executive Officer and announces changes to the Board of Directors
Board/Management Information
2021-10-20 English
Board/Management Information 2021
Board/Management Information
2021-10-20 English
BioPorto Successfully Completes Interim Analysis of Data from Pivotal Study of NGAL in Pediatrics with Encouraging Results
Regulatory Filings
2021-08-31 English
Regulatory Filings 2021
Regulatory Filings
2021-08-31 English
BioPorto Announces Q2 2021 Report
Interim / Quarterly Report H1 2021
2021-08-18 English
Earnings Release 2021
Earnings Release H1 2021
2021-08-18 English
Pipeline Update Regarding COVID-19 test
Regulatory Filings
2021-06-29 English
Regulatory Filings 2021
Regulatory Filings
2021-06-29 English
Managers’ transactions
Director's Dealing
2021-05-27 English
Director's Dealing 2021
Director's Dealing
2021-05-27 English
Board/Management Information 2021
Board/Management Information
2021-05-05 English
Peter Mørch Eriksen resigns as CEO of BioPorto A/S
Board/Management Information
2021-05-05 English
BioPorto initiates search for new CFO as Ole Larsen resigns
Board/Management Information
2021-04-26 English
Board/Management Information 2021
Board/Management Information
2021-04-26 English
Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act
Share Issue/Capital Change
2021-04-08 English
Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act
Share Issue/Capital Change
2021-04-08 English
BioPorto Announces the 2020 Annual Report
Remuneration Information
2021-03-17 English
BioPorto Announces the 2020 Annual Report
Annual Report FY 2020
2021-03-17 English
Report Publication Announcement 2021
Report Publication Announcement
2021-03-17 English
Pipeline Update from BioPorto
Regulatory Filings
2021-03-03 English
Earnings Release 2020
Earnings Release FY 2020
2021-03-03 English